• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

#VisualAbstract: Active malignancy during COVID-19 infection not associated with increased risk of ICU admission, intubation, or death

byConstance Wu
October 13, 2020
in Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Plant-based diets may be associated with lower risk of aggressive prostate cancer

Unvaccinated status increases risk of long COVID symptoms

2 Minute Medicine Rewind January 23, 2023

1. There was no significantly increased risk of ICU admission, intubation, or death among hospitalized patients with COVID-19 and active malignancy compared with a matched cohort of patients with COVID-19 and no malignancy.

Evidence Level Rating: 2 (Good)

Some institutions in the U.S. have reported higher rates of COIVD-related complications and death among patients with cancer. These studies have, in general, been limited. This has important implications, though; based on these data, the care of some patients with cancer has been altered, delayed, or even compromised. Therefore, the purpose of this matched cohort study was to examine morbidity and mortality due to COVID-19 among patients with cancer compared with those without. The primary outcome was a composite outcome consisting of ICU admission, intubation, and death. Included were a total of 585 adult patients, grouped into 117 patients with active malignancy (median [IQR] age = 72.5 [64.2-79.9] years, 54.7% male) and 468 patients without malignancy (median [IQR] age = 71.2 [62.1-79.6] years, 54.7% male). There were 29 deaths among patients in the cancer cohort compared with 100 deaths among patients in the non-cancer cohort (p = 0.894). There was no significant different in the primary outcome among patients with or without cancer. Furthermore, there was no significant difference in the primary outcome between hematologic or solid malignancies (p = 0.283). Additionally, there was no difference in outcome if patients received cytotoxic therapy within 90 days of admission (p = 0.446). In all, this study found no significant difference in the risk of ICU admission, intubation, or death among patients hospitalized for COVID-19 with and without active malignancy. This suggests that in the context of a robust, patient-centered discussion concerning risks and benefits, anticancer therapy may be able to be safely delivered or continue to be delivered to patients with COVID-19.

Click to read the study in JCO

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancerCoronavirusdeathICUICU admissionintubationmalignancySARS-CoV-2
Previous Post

#VisualAbstract: Sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis patients

Next Post

Low dose edoxaban prevents stroke in elderly patients with atrial fibrillation

RelatedReports

Vegetarian diet may lower incidence of colorectal cancer
Lifestyle

Plant-based diets may be associated with lower risk of aggressive prostate cancer

January 27, 2023
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Infectious Disease

Unvaccinated status increases risk of long COVID symptoms

January 25, 2023
Many new pediatric asthma cases attributable to obesity
Weekly Rewinds

2 Minute Medicine Rewind January 23, 2023

January 23, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 6

January 13, 2023
Next Post
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Low dose edoxaban prevents stroke in elderly patients with atrial fibrillation

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

Midwifery continuity of care model not associated with improved clinical outcomes compared to standard care

Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis

Increased proportion of out of hospital cardiac arrests at start at COVID-19

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options